These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27388872)

  • 1. TRIM5 gene polymorphisms in HIV-1-infected patients and healthy controls from Northeastern Brazil.
    Celerino da Silva R; Coelho AV; Arraes LC; Brandão LA; Crovella S; Guimarães RL
    Immunol Res; 2016 Dec; 64(5-6):1237-1242. PubMed ID: 27388872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of Trim5 polymorphisms on the clinical course of HIV-1 infection.
    van Manen D; Rits MA; Beugeling C; van Dort K; Schuitemaker H; Kootstra NA
    PLoS Pathog; 2008 Feb; 4(2):e18. PubMed ID: 18248091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic association of the antiviral restriction factor TRIM5alpha with human immunodeficiency virus type 1 infection.
    Speelmon EC; Livingston-Rosanoff D; Li SS; Vu Q; Bui J; Geraghty DE; Zhao LP; McElrath MJ
    J Virol; 2006 Mar; 80(5):2463-71. PubMed ID: 16474153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of human TRIM5alpha polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection.
    Javanbakht H; An P; Gold B; Petersen DC; O'Huigin C; Nelson GW; O'Brien SJ; Kirk GD; Detels R; Buchbinder S; Donfield S; Shulenin S; Song B; Perron MJ; Stremlau M; Sodroski J; Dean M; Winkler C
    Virology; 2006 Oct; 354(1):15-27. PubMed ID: 16887163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of common human TRIM5alpha variants in HIV-1 disease progression.
    Goldschmidt V; Bleiber G; May M; Martinez R; Ortiz M; Telenti A;
    Retrovirology; 2006 Aug; 3():54. PubMed ID: 16925802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of TRIM5 variants on the susceptibility to HIV-1 infection and disease progression in the Polish population.
    Bratosiewicz-Wąsik J; Miklasińska-Majdanik M; Wąsik TJ
    Ann Hum Genet; 2024 Mar; 88(2):154-170. PubMed ID: 37942942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokines SNPs in HIV-1+ Patients and Healthy Controls from Northeast Brazil: Association with Protection against HIV-1 Infection.
    Celerino da Silva R; Victor Campos Coelho A; Cláudio Arraes L; André Cavalcanti Brandão L; Lima Guimarães R; Crovella S
    Curr HIV Res; 2016; 14(4):340-5. PubMed ID: 26785888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of novel TRIM5alpha variants, Gly110Arg and G176del, on the anti-HIV-1 activity and the susceptibility to HIV-1 infection.
    Nakajima T; Nakayama EE; Kaur G; Terunuma H; Mimaya JI; Ohtani H; Mehra N; Shioda T; Kimura A
    AIDS; 2009 Oct; 23(16):2091-100. PubMed ID: 19710594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A TRIM5alpha exon 2 polymorphism is associated with protection from HIV-1 infection in the Pumwani sex worker cohort.
    Price H; Lacap P; Tuff J; Wachihi C; Kimani J; Ball TB; Luo M; Plummer FA
    AIDS; 2010 Jul; 24(12):1813-21. PubMed ID: 20588169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of cellular restriction gene (TRIM5α, BST-2) polymorphisms on the acquisition of HIV-1 and disease progression.
    Singh H; Samani D; Ghate MV; Gangakhedkar RR
    J Gene Med; 2018 Feb; 20(2-3):e3004. PubMed ID: 29282802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of TNF-alpha genetic variants and CCR5 Delta 32 on the vulnerability to HIV-1 infection and disease progression in Caucasian Spaniards.
    Veloso S; Olona M; García F; Domingo P; Alonso-Villaverde C; Broch M; Peraire J; Viladés C; Plana M; Pedrol E; López-Dupla M; Aguilar C; Gutiérrez M; Leon A; Tasias M; Gatell JM; Richart C; Vidal F
    BMC Med Genet; 2010 Apr; 11():63. PubMed ID: 20420684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the genetic variant CCR5Δ32 in HBV infection and HBV/HIV co-infection.
    Ellwanger JH; Kulmann-Leal B; Wolf JM; Michita RT; Simon D; Lunge VR; Chies JAB
    Virus Res; 2020 Feb; 277():197838. PubMed ID: 31837381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DEFB1 5'UTR polymorphisms modulate the risk of HIV-1 infection in Mexican women.
    Estrada-Aguirre JA; Osuna-Ramírez I; Prado Montes de Oca E; Ochoa-Ramirez LA; Ramirez M; Magallon-Zazueta LG; Gonzalez-Beltran MS; Cazarez-Salazar SG; Rangel-Villalobos H; Velarde-Felix JS
    Curr HIV Res; 2014; 12(3):220-6. PubMed ID: 25001249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIM5α H43Y Polymorphism and Susceptibility to HIV-1 Infection: A Meta-Analysis.
    Deng J; Chen Y; Ding D; Lu P; Yang X; Song Z; Zhu H
    AIDS Res Hum Retroviruses; 2015 Dec; 31(12):1213-8. PubMed ID: 26398573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene polymorphisms in CCR5, CCR2, SDF1 and RANTES among Chinese Han population with HIV-1 infection.
    Li H; Liu TJ; Hong ZH
    Infect Genet Evol; 2014 Jun; 24():99-104. PubMed ID: 24650919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of CCR5 and SDF-1 genetic variants and HIV infection in Indian population.
    Gupta A; Padh H
    Int J Immunogenet; 2015 Aug; 42(4):270-8. PubMed ID: 26096543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-C Single Nucleotide Polymorphism Associated with Increased Viral Load Level in HIV-1 Infected Individuals from Northeast Brazil.
    Celerino da Silva R; Moura RR; Victor Campos Coelho A; Arraes LC; Brandão LAC; Crovella S; Lima Guimarães R
    Curr HIV Res; 2017; 15(4):266-272. PubMed ID: 28494720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the CCR5-Delta32 HIV resistance allele and new mutations of the CCR5 gene in different Tunisian populations.
    Jlizi A; Edouard J; Fadhlaoui-Zid K; Frigi S; Debré P; Slim A; Theodorou I; El Gaaied AB; Carpentier W
    Hum Immunol; 2007 Dec; 68(12):993-1000. PubMed ID: 18191728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of CCR5 genotypes and HLA Class I B alleles in HIV-1 infected and uninfected injecting drug users from Rio de Janeiro, Brazil.
    Teixeira SL; Bastos FI; Hacker MA; Morgado MG
    Infect Genet Evol; 2009 Jul; 9(4):638-42. PubMed ID: 19460331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The frequency of CCR5Delta32 and CCR2-64I in southern Iranian normal population.
    Gharagozloo M; Doroudchi M; Farjadian S; Pezeshki AM; Ghaderi A
    Immunol Lett; 2005 Jan; 96(2):277-81. PubMed ID: 15585333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.